These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32525673)

  • 21. Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation.
    Sonar K; Mancera RL
    J Phys Chem B; 2022 Oct; 126(40):7916-7933. PubMed ID: 36179370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Characteristics of Monomeric Aβ42 on Fibril in the Early Stage of Secondary Nucleation Process.
    Noda K; Tachi Y; Okamoto Y
    ACS Chem Neurosci; 2020 Oct; 11(19):2989-2998. PubMed ID: 32794732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating effect of metallic ions on aggregation behavior of β-amyloid peptides by atomic force microscope and surface-enhanced Raman Scattering.
    Xie Y; Yu L; Fu Y; Sun H; Wang J
    Biomed Eng Online; 2021 Dec; 20(1):132. PubMed ID: 34969380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico investigation on the inhibition of Aβ
    Dutta M; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Feb; 36(3):741-752. PubMed ID: 28278027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer Abeta(1-42) monomer adsorbed on the self-assembled monolayers.
    Wang Q; Zhao J; Yu X; Zhao C; Li L; Zheng J
    Langmuir; 2010 Aug; 26(15):12722-32. PubMed ID: 20597530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ
    Li F; Zhan C; Dong X; Wei G
    Phys Chem Chem Phys; 2021 Sep; 23(34):18843-18854. PubMed ID: 34612422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of Inter-Molecular Interactions Between Single Aβ
    Feng L; Watanabe H; Molino P; Wallace GG; Phung SL; Uchihashi T; Higgins MJ
    J Mol Biol; 2019 Jul; 431(15):2687-2699. PubMed ID: 31075274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the Mixture of Aβ24 and Aβ42 Peptides from Atomistic Simulations.
    Nguyen PH; Derreumaux P
    J Phys Chem B; 2022 Dec; 126(50):10689-10696. PubMed ID: 36493347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin Inhibits Aβ42 Aggregation and Prevents Aβ42-Induced Membrane Disruption.
    Long K; Williams TL; Urbanc B
    Biochemistry; 2019 Nov; 58(45):4519-4529. PubMed ID: 31642314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mobile precursor determines amyloid-β peptide fibril formation at interfaces.
    Shen L; Adachi T; Vanden Bout D; Zhu XY
    J Am Chem Soc; 2012 Aug; 134(34):14172-8. PubMed ID: 22867029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease.
    Horsley JR; Jovcevski B; Wegener KL; Yu J; Pukala TL; Abell AD
    Biochem J; 2020 Jun; 477(11):2039-2054. PubMed ID: 32427336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin Modulates the Kinetics of Zinc-Induced Aggregation of Amyloid-β Peptides.
    Radko SP; Khmeleva SA; Mantsyzov AB; Kiseleva YY; Mitkevich VA; Kozin SA; Makarov AA
    J Alzheimers Dis; 2018; 63(2):539-550. PubMed ID: 29630553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
    Lee C; Ham S
    J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42.
    Chen YR; Glabe CG
    J Biol Chem; 2006 Aug; 281(34):24414-22. PubMed ID: 16809342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free Cholesterol Accelerates Aβ Self-Assembly on Membranes at Physiological Concentration.
    Hashemi M; Banerjee S; Lyubchenko YL
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.